EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trial‐related blood sampling and red blood cell transfusions in preterm infants

Anna Elisabet Lewis, Susanne S Kappel iD, Samya Hussain, Per T Sangild, Gitte Zachariassen iD, Lise Aunsholt

Acta Paediatrica · 2023

DOI: 10.1111/apa.16948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, 2023. Verfasst von Anna Elisabet Lewis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Comparative Pediatrics and Nutrition, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Erythropoietin, Anemia, Neonatal, Infant, Premature, Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To determine if trial‐related blood sampling increases the risk of later red blood cell (RBC) transfusion in very preterm infants, we compared the volume of clinical‐ and trial‐related blood samples, in a specific trial and correlated to subsequent RBC transfusion.

Methods

For 193 very preterm infants, participating in the FortiColos trial (NCT03537365), trial‐related blood volume drawn was in accordance with ethical considerations established by the European Commission. Medical records were reviewed to assess the number and accumulated volume (mL/kg) of blood samples (both clinical‐ and trial‐related). Data were compared with the need of RBC transfusions during the first 28 days of life.

Results

Mean (SD) gestational age and birth weight was 28 ± 1 weeks and 1168 ± 301 g. In total, 11% of total blood volume was drawn for sampling (8.1 ± 5.1 mL/kg) and trial‐related sampling accounted for 1.6 ± 0.6 mL/kg. Trial‐related blood sampling had no impact on RBC transfusion ( p = 0.9).

Conclusion

Clinical blood sampling in very preterm infants is associated with blood loss and subsequent need for RBC transfusions. In a specific trial requiring blood samples, we found no additional burden of trial‐related blood sampling. The study suggests that trial‐related sampling is safe if European criteria are followed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythropoietinAnemia, NeonatalInfant, Premature, DiseasesInfantInfant, NewbornHumansInfant, PrematureErythrocyte TransfusionInfant, Very Low Birth Weight

Stichwörter der Autor:innen

anaemia of prematurityblood samplingprematurityred blood cell transfusion

Substanzen

Erythropoietin

Autor:innen und Institutionen

  • Comparative Pediatrics and Nutrition, University of Copenhagen, Copenhagen, Denmark.
  • Department of Neonatology, Nordsjaellands Hospital, Hillerød, Denmark.
  • Department of Neonatology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Susanne S Kappel, Gitte Zachariassen

Zitieren

APA

Lewis, A. E., Kappel, S. S., Hussain, S., Sangild, P. T., Zachariassen, G., & Aunsholt, L. (2023). Trial‐related blood sampling and red blood cell transfusions in preterm infants. Acta Paediatrica. https://doi.org/10.1111/apa.16948

Vancouver

Lewis AE, Kappel SS, Hussain S, Sangild PT, Zachariassen G, Aunsholt L. Trial‐related blood sampling and red blood cell transfusions in preterm infants. Acta Paediatrica. 2023. doi:10.1111/apa.16948

BibTeX
@article{Lewis2023,
  author = {Lewis, Anna Elisabet and Kappel, Susanne S and Hussain, Samya and Sangild, Per T and Zachariassen, Gitte and Aunsholt, Lise},
  title = {Trial‐related blood sampling and red blood cell transfusions in preterm infants},
  journal = {Acta Paediatrica},
  year = {2023},
  doi = {10.1111/apa.16948}
}
Kostenlos starten →